$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading Week 29/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. in week 29/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,204 | 0 | 13,246 | 12 K to 13.2 K (+10.00 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Grant | A | 0.00 | 1,204 | 0 | 10,075 | 8.9 K to 10.1 K (+13.57 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,204 | 0 | 2,306 | 1.1 K to 2.3 K (+109.26 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Grant | A | 0.00 | 1,204 | 0 | 3,146 | 1.9 K to 3.1 K (+62.00 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Option Exercise | A | 145.22 | 3,196 | 464,123 | 3,196 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Grant | A | 0.00 | 2,407 | 0 | 2,407 | 0 to 2.4 K |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 145.22 | 3,196 | 464,123 | 3,196 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 2,407 | 0 | 2,407 | 0 to 2.4 K |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 9.82 | 12,500 | 122,779 | 0 | |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Payment of Exercise | F | 148.73 | 7,341 | 1,091,827 | 552,725 | 560.1 K to 552.7 K (-1.31 %) |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 9.82 | 12,500 | 122,779 | 560,066 | 547.6 K to 560.1 K (+2.28 %) |